Clinical Trials Directory

Trials / Completed

CompletedNCT06575504

Ultrasonographical of Suprarenal Gland in High Risk Neonates

Ultrasonographical Study of Suprarenal Gland in High Risk Neonates

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
1 Day – 10 Days
Healthy volunteers
Not accepted

Summary

Observation study The aim is to study the suprarenal blood flow among high-risk neonates and its relation to the risk factors

Detailed description

Ultrasonographical study of the suprarenal gland in high risk newborn infants Al-Zhrraa University hospital Sample size 105 Inclusion criteria: 1- High-risk newborn 2- Need NICU admission Exclusion criteria: Cases with Major congenital anomalies and NEC Primary outcome: Abnormal suprarenal blood flow Informed consent will be obtained from all parents and mothers of the newborns enrolled in the study. All cases will be subjected to - Full history taking: (prenatal -natal - postnatal). According to the routine admission sheet of NICU of Alzahraa University Hospital, Faculty of Medicine for girls, AL-Azhar University, Cairo, Egypt. Through clinical examination (APGAR score -estimation of gestational age using modified Ballard score \"Ballard, 1991\" - body weight - severity of respiratory illness using Downs score and Silverman\'s score). Laboratory investigations: * Blood gases. * Serum electrolytes and blood glucose. * CBC. CRP. * Liver and kidney functions. Radiological evaluation: in the form of Abdominal and chest x-ray. Ultrasonographical studies were done for suprarenal gland blood flow. - Statistical Analysis, Data were collected, revised, coded, and entered into the statistical package for social science (SPSS)

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasonographical examinationStudy size and Doppler / blood flow / of the suprarenal gland

Timeline

Start date
2023-11-15
Primary completion
2024-07-15
Completion
2024-08-15
First posted
2024-08-28
Last updated
2024-08-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06575504. Inclusion in this directory is not an endorsement.